ASH in Cuba: Unmasking Challenges and Opportunities in Hematology
Following ASH's executive committee's retreat in Havana, Cuba, Dr. Gotlib discusses lessons, challenges and opportunities for hematologists and the community, with commenta
A New, Uninhibited Approach to the Treatment of Hemophilia A
Dr. Garcia covers a study that suggests that emicizumab, a bispecific antibody, may allow many patients with Hemophilia A to achieve better hemostasis and might even be a b
Co-chairs Drs. Ken Anderson and Martin Tallman encourage attending this year's meeting to learn about clinical updates in the field of malignant hematology.
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
Dr. Moss looks at updates regarding the genomic classification of and treatment approaches to AML.
September/October 2016 Volume 13, Issue 5
View all Features articles
View all Diffusion articles
Dr. Charles Abrams talks about the importance of ASH's effort to promote diversity through its Minority Recruitment Initiative's programs.
View all president's column articles
View all Ask the Hematologist articles
View all Op-Ed articles
View all Mini Review articles
The National Heart Lung and Blood Institute (NHLBI) has released its strategic vision which highlights the goals and research priorities that will inform its policy and funding decisions for heart, lung, blood, and sleep diseases (HLBS) in the next several years. ASH participated in the NHLBI’s strategic visioning process and submitted additional comments when the NHLBI’s draft strategic priorities were released.
The Centers for Medicare and Medicaid Services (CMS) released the annual set of proposals governing payments for services provided to patients admitted to the hospital, commonly referred to as the hospital inpatient prospective payment system (IPPS). ASH explores how this will affect hematologists.
As part of the American Society of Hematology’s (ASH)
multifaceted initiative to address the burden of sickle cell disease, ASH is in
the process of working with stakeholders to improve access to care for
individuals with sickle cell disease.
Included in this effort is
On March 8, 2016, the Center for Medicare and Medicaid Services (CMS) proposed a new experiment in payment rates for physician-administered drugs such as chemotherapy. This plan would change the current formula for drug payment so that payments for expensive drugs are reduced in certain areas of the country. In a second phase, CMS would be able to adopt certain tools to further adjust pricing for drugs.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology